SCHEMBL25246787

SCHEMBL25246787

CCNc1nc(NCc2ccco2)c2cc(O)c(O)cc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL1 P55085 1/20 0.56
MAPT P10636 8/20 0.54
MAPK1 P28482 6/20 0.54
NPSR1 Q6W5P4 6/20 0.54
KMT2A Q03164 6/20 0.54
GAA P10253 2/20 0.54
BLM P54132 2/20 0.54
ADRB2 P07550 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
KDM4E B2RXH2 7/20 0.54
ALDH1A1 P00352 4/20 0.52
LMNA P02545 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
XBP1 P17861 2/20 0.52
HTT P42858 2/20 0.52
GPR55 Q9Y2T6 1/20 0.52
SOS1 Q07889 3/20 0.50
HPGD P15428 3/20 0.49
USP2 O75604 1/20 0.49
NR2F2 P24468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30455380 0.84 MAPK1 (0.65) F2RL1MAPTMAPK1NPSR1KMT2A
SCHEMBL30455471 0.83 MAPT (0.72) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL25253405 0.80 KDM4E (0.48) F2RL1MAPTMAPK1NPSR1KMT2A
SCHEMBL30455311 0.76 MAPT (0.81) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL27253686 0.73 MAPK1 (0.57) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL31620275 0.73 MAPK1 (0.57) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL31620289 0.73 MAPK1 (0.57) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL27253780 0.73 MAPK1 (0.57) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL1391175 0.73 MAPT (0.77) MAPTMAPK1NPSR1KMT2AGAA
SCHEMBL10031962 0.71 MAPT (0.98) MAPTMAPK1NPSR1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF UNIV AJOU IND ACADEMIC COOP FOUND (KR) 2025-02-13 US disclosed
WO-2023121429-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF 아주대학교산학협력단 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051290-A1 NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF ADORA2A, HCRTR1, ADORA1 F2RL1 459/4885MAPT 4331/4885MAPK1 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.